Clinical and hemodynamic outcomes of 'all-comers' undergoing transapical aortic valve implantation: Results from the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA)

Autor: D'Onofrio, Augusto, Rubino, P, Fusari, M, Salvador, L, Musumeci, F, Rinaldi, M, Vitali, Eo, Glauber, M, Bartolomeo, Di, R, Alfieri, Or, Polesel, E, Aiello, M, Casabona, R, Livi, U, Grossi, C, Cassese, M, Pappalardo, A, Gherli, T, Stefanelli, G, Faggian, Giuseppe, Gerosa, G.
Přispěvatelé: D'Onofrio, A, Rubino, P, Fusari, M, Salvador, L, Musumeci, F, Rinaldi, M, Vitali, Eo, Glauber, M, Di Bartolomeo, R, Alfieri, Ottavio, Polesel, E, Aiello, M, Casabona, R, Livi, U, Grossi, C, Cassese, M, Pappalardo, A, Gherli, T, Stefanelli, G, Faggian, Gg, Gerosa, G., A. D’Onofrio, P. Rubino, M. Fusari, L. Salvador, F. Musumeci, M. Rinaldi, E.O. Vitali, M. Glauber, R. Di Bartolomeo, O.R. Alfieri, E. Polesel, M. Aiello, R. Casabona, U. Livi, C. Grossi, M. Cassese, A. Pappalardo, T. Gherli, G. Stefanelli, G.G. Faggian, G. Gerosa
Rok vydání: 2011
Předmět:
Male
Pulmonary and Respiratory Medicine
Aortic valve
Cardiac Catheterization
medicine.medical_specialty
Logistic euroscore
Time Factors
Intraoperative Complication
Hemodynamics
Kaplan-Meier Estimate
Risk Assessment
chemistry.chemical_compound
patient survival
Risk Factors
Internal medicine
Odds Ratio
medicine
Humans
surgery
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
Humans
Italy

In patient
Prospective Studies
Registries
Aged
Aged
80 and over

Heart Valve Prosthesis Implantation
Creatinine
Chi-Square Distribution
aortic valve implantation
business.industry
Aortic Valve Stenosis
Odds ratio
Hospitals
Confidence interval
Surgery
Survival Rate
Logistic Models
Treatment Outcome
medicine.anatomical_structure
Italy
chemistry
Aortic Valve
Heart Valve Prosthesis
Cardiology
Female
Cardiology and Cardiovascular Medicine
business
Learning Curve
Zdroj: The Journal of Thoracic and Cardiovascular Surgery. 142:768-775
ISSN: 0022-5223
Popis: OBJECTIVE: The aim of this study was to assess clinical and hemodynamic outcomes of transapical aortic valve implantation (TA-TAVI) in patients enrolled in the Italian Registry of Trans-Apical Aortic Valve Implantation (I-TA). METHODS: From April 2008 until November 2010, 504 patients from 20 Italian centers were enrolled in the I-TA registry. Mean logistic EuroSCORE and Society of Thoracic Surgeons score were 24% ± 16% and 11% ± 4%, respectively. Mean follow-up was 9.2 ± 6.5 months (range, 1-26 months). Outcomes were analyzed according to intraoperative complications, procedural volume (high-volume centers, >20 cases; low-volume centers, < 20 cases) and learning curve (first 50% cases vs second 50% cases of each center). RESULTS: All-cause overall mortality was 8.3% (42 patients). Device success was 99% (500/504 patients). Intraoperative severe complications occurred in 24 (4.8%) patients. Overall 2-year survival was 71.5% ± 6.2%. At discharge, peak and mean gradients were 16.4 ± 11.2 and 8.7 ± 4.1 mm Hg, respectively, and effective orifice area was 1.67 cm(2). These values remained stable at 3, 6, and 12 months after surgery. Independent risk factors for mortality after TA-TAVI were as follows: New York Heart Association class III and IV (odds ratio [OR], 4.43; 95% confidence intervals [CI], 1.28-15.40; P = .02); logistic EuroSCORE greater than 20 (OR, 1.83; 95% CI, 1.02-3.29; P = .04); creatinine concentration greater than 200 μmol/L (OR, 2.56; 95% CI, 1.07-6.15; P = .03), and intraoperative complications (OR, 5.80; 95% CI, 2.68-12.55; P < .001). There were no significant differences in outcomes between high- and low-volume centers and between the first and the second 50% of cases. CONCLUSIONS: TA-TAVI represents a safe and effective alternative treatment for patients who are inoperable or at high risk for surgery. The occurrence of an intraoperative complication significantly affects survival. Procedural volume and learning curve have no impact on patient survival.
Databáze: OpenAIRE